November 29, 2016 / 2:55 PM / a year ago

BRIEF-A1M Pharma successfully conducts preclinical toxicology/safety studies within preeclampsia

Nov 29 (Reuters) - A1M Pharma AB :

* Says has successfully and according to plan conducted the first part of the company’s toxicology/safety studies with the pharmaceutical compound in the company’s candidate drug ROSGard

* In the studies, a maximum tolerated dose (MTD) has been established in two different animal models

* These results will be used to establish the dosage levels to be used in the GLP-compliant toxicology studies

Source text: bit.ly/2gFcqeQ

Further company coverage:

Gdynia Newsroom

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below